drugset / Trial / NCT03026088
Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Participants
Phase 4
Terminated
20 enrolled
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, open label, interventional, multi-center, phase 4 pilot study.
Timeline
- Start
- 2017-03-21
- Primary completion
- 2018-12-26
- Completion
- 2018-12-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bisoprolol | Other / unclassified | 10 mg | Oral |